Larson Financial Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.4K | Sell |
2,478
-106
| -4% | -$2.93K | ﹤0.01% | 959 |
|
|
2025
Q1 | $73.3K | Buy |
2,584
+1,318
| +104% | +$37.4K | ﹤0.01% | 876 |
|
|
2024
Q4 | $52.6K | Buy |
1,266
+356
| +39% | +$14.8K | ﹤0.01% | 881 |
|
|
2024
Q3 | $60.8K | Buy |
910
+317
| +53% | +$21.2K | ﹤0.01% | 844 |
|
|
2024
Q2 | $70.4K | Buy |
593
+561
| +1,753% | +$66.6K | ﹤0.01% | 729 |
|
|
2024
Q1 | $3.41K | Hold |
32
| – | – | ﹤0.01% | 1264 |
|
|
2023
Q4 | $3.18K | Sell |
32
-83
| -72% | -$8.25K | ﹤0.01% | 1282 |
|
|
2023
Q3 | $11.9K | Sell |
115
-8
| -7% | -$826 | ﹤0.01% | 951 |
|
|
2023
Q2 | $14.9K | Buy |
123
+4
| +3% | +$486 | ﹤0.01% | 820 |
|
|
2023
Q1 | $18.3K | Hold |
119
| – | – | ﹤0.01% | 763 |
|
|
2022
Q4 | $21.4K | Hold |
119
| – | – | ﹤0.01% | 681 |
|
|
2022
Q3 | $14K | Hold |
119
| – | – | ﹤0.01% | 707 |
|
|
2022
Q2 | $17K | Buy |
119
+8
| +7% | +$1.14K | ﹤0.01% | 583 |
|
|
2022
Q1 | $19K | Sell |
111
-70
| -39% | -$12K | ﹤0.01% | 540 |
|
|
2021
Q4 | $46K | Buy |
181
+40
| +28% | +$10.2K | 0.01% | 395 |
|
|
2021
Q3 | $54K | Buy |
141
+40
| +40% | +$15.3K | 0.01% | 283 |
|
|
2021
Q2 | $24K | Sell |
101
-36
| -26% | -$8.55K | 0.01% | 401 |
|
|
2021
Q1 | $18K | Buy |
137
+11
| +9% | +$1.45K | 0.01% | 434 |
|
|
2020
Q4 | $13K | Sell |
126
-1,128
| -90% | -$116K | ﹤0.01% | 456 |
|
|
2020
Q3 | $89K | Sell |
1,254
-298
| -19% | -$21.2K | 0.04% | 137 |
|
|
2020
Q2 | $100K | Buy |
1,552
+1,535
| +9,029% | +$98.9K | 0.05% | 134 |
|
|
2020
Q1 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 490 |
|